全文获取类型
收费全文 | 358篇 |
免费 | 27篇 |
专业分类
385篇 |
出版年
2022年 | 2篇 |
2021年 | 3篇 |
2019年 | 2篇 |
2018年 | 2篇 |
2017年 | 2篇 |
2016年 | 5篇 |
2015年 | 15篇 |
2014年 | 9篇 |
2013年 | 20篇 |
2012年 | 23篇 |
2011年 | 22篇 |
2010年 | 16篇 |
2009年 | 13篇 |
2008年 | 22篇 |
2007年 | 17篇 |
2006年 | 17篇 |
2005年 | 23篇 |
2004年 | 8篇 |
2003年 | 15篇 |
2002年 | 20篇 |
2001年 | 23篇 |
2000年 | 7篇 |
1999年 | 5篇 |
1998年 | 7篇 |
1997年 | 7篇 |
1996年 | 5篇 |
1994年 | 2篇 |
1993年 | 2篇 |
1992年 | 5篇 |
1991年 | 9篇 |
1990年 | 5篇 |
1989年 | 2篇 |
1988年 | 7篇 |
1985年 | 5篇 |
1984年 | 6篇 |
1983年 | 3篇 |
1981年 | 2篇 |
1980年 | 2篇 |
1979年 | 2篇 |
1976年 | 1篇 |
1975年 | 2篇 |
1974年 | 3篇 |
1970年 | 4篇 |
1969年 | 1篇 |
1967年 | 1篇 |
1966年 | 1篇 |
1957年 | 1篇 |
1950年 | 1篇 |
1948年 | 1篇 |
1927年 | 1篇 |
排序方式: 共有385条查询结果,搜索用时 15 毫秒
81.
J Heins P Welker C Sch?nlein I Born B Hartrodt K Neubert D Tsuru A Barth 《Biochimica et biophysica acta》1988,954(2):161-169
The substrate specificity of dipeptidyl peptidase IV (dipeptidyl peptide hydrolase, EC 3.4.14.5) from pig kidney and proline-specific endopeptidase from Flavobacterium meningosepticum, was investigated with a series of N-terminal unprotected (dipeptidyl peptidases IV) and succinylated dipeptidyl-p-nitroanilides (proline-specific endopeptidase). Both enzymes are specific for the S configuration of the amino-acid residue in P1 and P2 position if the penultimate residue is proline. In the case of alanine substrates (Ala in P1, dipeptidyl peptidase IV hydrolyzes such compounds where the configuration of the P2 residue is R. The penultimate residue with dipeptidyl peptidase IV can be, beside proline and alanine, dehydroproline, hydroxyproline and pipecolic acid. Proline substrates (Pro in P1) with an R configuration in P2 are inhibitors of the hydrolysis of proline substrates with an S,S configuration in an uncompetitive (dipeptidyl peptide IV) or mixed inhibition type (proline-specific endopeptidase). Derivatives of Gly-Pro-pNA where the N-terminal amino group is methylated are hydrolyzed by dipeptidyl peptidase IV. 相似文献
82.
Rathie Rajendram Richard WJ Lee Mike J Potts Geoff E Rose Rajni Jain Jane M Olver Fion Bremner Steven Hurel Anne Cook Rao Gattamaneni Marjorie Tomlinson Nicholas Plowman Catey Bunce Sandra P Hollinghurst Laura Kingston Sue Jackson Andrew D Dick Nichola Rumsey Olivia C Morris Colin M Dayan Jimmy M Uddin 《Trials》2008,9(1):1-17
Background
Intravenous recombinant tissue plasminogen activator (rt-PA) is approved for use in selected patients with ischaemic stroke within 3 hours of symptom onset. IST-3 seeks to determine whether a wider range of patients may benefit.Design
International, multi-centre, prospective, randomized, open, blinded endpoint (PROBE) trial of intravenous rt-PA in acute ischaemic stroke. Suitable patients must be assessed and able to start treatment within 6 hours of developing symptoms, and brain imaging must have excluded intracerebral haemorrhage. With 1000 patients, the trial can detect a 7% absolute difference in the primary outcome. With3500 patients, it can detect a 4.0% absolute benefit & with 6000, (mostly treated between 3 & 6 hours), it can detect a 3% benefit.Trial procedures
Patients are entered into the trial by telephoning a fast, secure computerised central randomisation system or via a secure web interface. Repeat brain imaging must be performed at 24–48 hours. The scans are reviewed 'blind' by expert readers. The primary measure of outcome is the proportion of patients alive and independent (Modified Rankin 0–2) at six months (assessed via a postal questionnaire mailed directly to the patient). Secondary outcomes include: events within 7 days (death, recurrent stroke, symptomatic intracranial haemorrhage), outcome at six months (death, functional status, EuroQol).Trial registration
ISRCTN25765518 相似文献83.
J. Stano P. Nemec P. Kovcs D. Kkoniov D. Likov K. Neubert 《Engineering in Life Science》1997,17(2):195-201
A poppy cell suspension culture was permeabilized by Tween 80 and immobilized by glutaraldehyde. The α-Galactosidase in these cells showed an optimum pH level at 5.2 and an optimum temperature at 70 °C. Enzyme hydrolysis was linear for 3 h, reaching 86% conversion. A very good level of storage stability was achieved when using dry catalyst and immobilized cells in 0.15 M NaCl solution (with the addition of chloramphenicol, [1-methyldodecy1)-dimethylamin-4-oxide (ATDNO), chlortetracycline hydrochloride (CLCTC)] or by freezing them in 0.15 M NaCl solution. 相似文献
84.
M Brandsch I Knütter F Thunecke B Hartrodt I Born V B?rner F Hirche G Fischer K Neubert 《European journal of biochemistry》1999,266(2):502-508
To elucidate the decisive structural factors relevant for dipeptide-carrier interaction, the affinity of short amide and imide derivatives for the intestinal H+/peptide symporter (PEPT1) was investigated by measuring their ability to inhibit Gly-Sar transport in Caco-2 cells. Dipeptides with proline or alanine in the C-terminal position displayed affinity constants (Ki) of 0.15-1.2 mM and 0.08-9.5 mM, respectively. There was no clear relationship between hydrophobicity, size or ionization status of the N-terminal amino acid and the affinity of the dipeptides. However, analyzing the individual peptide bond conformations of Xaa-Pro dipeptides, a striking correlation between the cis/trans ratios (trans contents 24-70%) and the affinity constants was observed. After correcting the Ki values for the incompetent cis isomers, the Ki corr values of most dipeptides were in a small range of 0.1-0.16 mM. This result revealed the decisive role of peptide bond conformation even for a transport protein that is quite promiscuous in substrate translocation. When measuring affinity constants of Xaa-Pro and Xaa-Sar dipeptides, the cis/trans ratios cannot be ignored. Lower affinities of Lys-Pro, Arg-Pro and Pro-Pro indicate that additional molecular factors affect their binding at PEPT1. The Ki values obtained for the corresponding Xaa-Ala dipeptides support this conclusion. Potential substrates or inhibitors of peptide transport were found among Xaa-piperidides and Xaa-thiazolidides. Dipeptides with N-terminal proline displayed a very diverse affinity profile. However, in contrast to current knowledge, several Pro-Xaa dipeptides such as Pro-Leu, Pro-Tyr and Pro-Pro are recognized by PEPT1 with appreciable affinities. Binding seems mainly determined by the hydrophobicity of the C-terminal amino acid and the rigidity of the structure. 相似文献
85.
86.
Sarita AY Hartgring Cynthia R Willis Johannes WJ Bijlsma Floris PJG Lafeber Joel AG van Roon 《Arthritis research & therapy》2012,14(3):R137
Introduction
We sought to investigate the capacity of interleukin (IL)-7 to enhance collagen-induced arthritis and to study by what mechanisms this is achieved.Methods
Mice received multiple injections with IL-7 or phosphate-buffered saline (PBS) as a control. Arthritis severity and incidence were determined by visual examination of the paws. Joint destruction was determined by assessing radiographs and immunohistochemistry of the ankle joints. Total cellularity and numbers of T-cell and B-cell subsets were assessed, as well as ex vivo production of interferon-γ (IFN-γ), IL-17, and IL-4. Proinflammatory mediators were measured in serum with multianalyte profiling.Results
IL-7 increased arthritis severity and radiology-assessed joint destruction. This was consistent with IL-7-increased intensity of cell infiltrates, bone erosions, and cartilage damage. Splenic CD19+ B cells and CD19+/GL7+ germinal center B cells, as well as CD4 and CD8 numbers, were increased by IL-7. IL-7 expanded memory T cells, associated with increased percentages of IFN-γ-, IL-4-, and IL-17-producing CD4+ T cells. On antigen restimulation of draining lymph node cells in vitro IL-7 treatment was found to increase IFN-γ and IL-17 production, whereas IL-4 was reduced. IL-7 also increased concentrations of proinflammatory mediators, indicative of T-cell activation (sCD40L), vascular activation (VCAM-1, VEGF), tissue destruction (fibroblast growth factor-basic (FGF-b), LIF), and chemotaxis (MIP-1γ, MIP-3β, lymphotactin, MDC, and MCP-5).Conclusions
In arthritic mice, IL-7 causes expansion of T and B cells, associated with increased levels of proinflammatory mediators. IL-7 intensifies arthritis severity and joint destruction, accompanied by increased Th1 and Th17 activity. These data indicate that IL-7 could be an important mediator in arthritic conditions and that targeting IL-7 or its receptor represent novel therapeutic strategies. 相似文献87.
88.
Till JH Becerra M Watty A Lu Y Ma Y Neubert TA Burden SJ Hubbard SR 《Structure (London, England : 1993)》2002,10(9):1187-1196
Muscle-specific kinase (MuSK) is a receptor tyrosine kinase expressed selectively in skeletal muscle. During neuromuscular synapse formation, agrin released from motor neurons stimulates MuSK autophosphorylation in the kinase activation loop and in the juxtamembrane region, leading to clustering of acetylcholine receptors. We have determined the crystal structure of the cytoplasmic domain of unphosphorylated MuSK at 2.05 A resolution. The structure reveals an autoinhibited kinase domain in which the activation loop obstructs ATP and substrate binding. Steady-state kinetic analysis demonstrates that autophosphorylation results in a 200-fold increase in k(cat) and a 10-fold decrease in the K(m) for ATP. These studies provide a molecular basis for understanding the regulation of MuSK catalytic activity and suggest that an additional in vivo component may contribute to regulation via the juxtamembrane region. 相似文献
89.
90.
On the PAM matrix model of protein evolution 总被引:2,自引:0,他引:2
The internal consistency of the PAM matrix model of protein evolution is
here investigated. The 1 PAM matrix has been constructed from amino acid
replacements observed in closely related sequences. Such replacements are
of two types, those that do not require an intermediate amino acid
replacement and those that do. The second type of replacement must
generally be produced by a repetition of the first. This allows data on the
first type to be used in predicting data on the second type so that some
elements of the 1 PAM matrix may be used to predict others. A discrepancy
of more than two orders of magnitude is found between the predictions and
the data when this is carried out. This is partly accounted for by an error
in constructing the matrix. However, it also seems necessary that the basic
model be modified. Several possibilities are considered. One of these is to
incorporate a site-dependent spectrum of mutabilities associated with each
amino acid.
相似文献